The letter address two concerns:
1. Outpatients are rapidly forced off opioid tapering.
2. Opioid tapering that requires aggressive opioid dose reductions over time
The physicians group said opioid tapering guidelines were created to decrease patient harm, but patients who use opioids for chronic pain face additional and serious harm due to rapid opioid tapering dose reductions “that are aggressive and unrealistic.”
The group of international physicians call for a “compassionate systems for opioid tapering,” and “patient advisory boards … to ensure that patient-centered systems are developed and patient rights are protected.”
The letter petitions HHS to use patient data and include pain specialists when making patient pain management plans.
More articles on opioids:
Opioids have little benefit in long-term pain management, study finds
Daily drug for opioid use disorder more cost-effective than monthly injection
DEA failed to curb opioid distribution in West Virginia, Congress says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
